Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Rectal Cancer (LARC) × XELOX × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 4 Rectal Neoplasms 4 Colorectal Neoplasms 4 Colonic Neoplasms 2 Neoplasm Metastasis 1 Locally Advanced Rectal Cancer (LARC) 1 Gastric Cancer Stage 1 Adenocarcinoma of the Lower Rectum 1

Interventions

dostarlimab 2 Radiotherapy 2 sintilimab 1 XELOX 1 Oxaliplatin 1 Neoadjuvant Therapy 1 Immune Checkpoint Inhibitors 1 Endoscopic Mucosal Resection 1 Drug Therapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07381777 2026-02-02

IMMUNOSTAR

Gruppo Oncologico Italiano di Ricerca Clinica

Phase 2 Not yet recruiting

Gastrointestinal

Locally Advanced Rectal Cancer (LARC)

Data powered by HemOnc (CC BY 4.0) Colophon ⚡